Overview
Angelini Pharma Polska is part of an Italian pharmaceutical company with 100 years of experience in the production and distribution of medicinal products. It focuses on central nervous system areas, including the treatment of depression, pain and rare diseases, as well as colds and their symptoms, and also offers OTC products.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
14 1600 1127 1843 3429 8000 0001- 84 1600 1127 1843 3429 8000 0002
- 57 1600 1127 1843 3429 8000 0003
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 19,821PLN 19,821 |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Angelini Pharma Polska holds 28 active trademarks registered with the Polish Patent Office. 14 marks have expired or were not registered. The first mark was filed in 1974.
| Mark | Protected until | |
|---|---|---|
| WYPROSTUJ SPOJRZENIE | Jan 2, 2035 | |
| MAGVIT D<sub>3</sub><br /> | Dec 16, 2032 | |
| NIE JESTEŚ SAM/A Kampania społeczna na rzecz osób chorych na epilepsję | Dec 13, 2032 | |
| NIE JESTEŚ SAM/A Kampania społeczna na rzecz osób chorych na epilepsję | Dec 6, 2032 | |
| NIE JESTEŚ SAM/A Kampania społeczna na rzecz osób chorych na epilepsję | Dec 6, 2032 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the President of the Management Board acting independently is authorized to make declarations of will on behalf of the company; in the case of a multi-member management board, the President of the Management Board acting independently, two members of the management board (other than the President of the Management Board) acting jointly, or one member of the management board (other than the President of the Management Board) acting jointly with a commercial proxy is authorized to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Angelini Pharma S.p.a. | 22,760 | $614,802.81 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Servier Polska Servicessp. z o.o. | $125,526,921.78 | servier.pl | ||
| Stada Pharmsp. z o.o. | $98,071,375.86 | walmark.eu | ||
| Olympus Polskasp. z o.o. | $77,594,927.17 | olympus.pl | ||
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl | ||
| AO East Europesp. z o.o. | $12,156,227.53 | aoeasteurope.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-08-05 | Address change (Al. Aleje Jerozolimskie 181b, 02-222, Warszawa → Ul. Aleje Jerozolimskie 181b, 02-222, Warszawa) | |
| 2021-06-14 | Address change (Podleśna 83, 05-552, Łazy → Al. Aleje Jerozolimskie 181b, 02-222, Warszawa) | |
| 2013-02-06 | Name change (Medagro International → Angelini Pharma Polska) | |
| 2009-06-03 | Address change (Wilcza 46, 00-679, Warszawa → Podleśna 83, 05-552, Łazy) | |
| 2006-12-12 | Address change (Marszałkowska 77/79, 00-683, Warszawa → Wilcza 46, 00-679, Warszawa) |
FAQ
Last updated: 2026-10-07